Shuying Dong
Beijing, 100043, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Correction: YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.
Journal: Molecular cancer
Published: January 12, 2026
Progression of hepatocellular carcinoma after radiofrequency ablation: Current status of research.
Journal: Frontiers in oncology
Published: August 31, 2022
Arsenic trioxide inhibits angiogenesis of hepatocellular carcinoma after insufficient radiofrequency ablation via blocking paracrine angiopoietin-1 and angiopoietin-2.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: July 18, 2022
Metformin promotes the normalization of abnormal blood vessels after radiofrequency ablation deficiency in hepatocellular carcinoma by microRNA-302b-3p targeting thioredoxin-interacting protein.
Journal: Acta biochimica Polonica
Published: March 29, 2022
Circular BANP knockdown inhibits the malignant progression of residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Journal: Chinese medical journal
Published: January 05, 2022
Circular BANP knockdown inhibits the malignant progression of residual hepatocellular carcinoma after insufficient radiofrequency ablation.
Journal: Chinese medical journal
Published: March 19, 2021
ICAM-1 Activates Platelets and Promotes Endothelial Permeability through VE-Cadherin after Insufficient Radiofrequency Ablation.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 13, 2020
ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy.
Journal: Frontiers in oncology
Published: November 29, 2019
ATPase inhibitory factor 1 inhibition improves the antitumor of YC-1 against hepatocellular carcinoma.
Journal: Oncology letters
Published: January 14, 2018
Metformin exhibits the anti-proliferation and anti-invasion effects in hepatocellular carcinoma cells after insufficient radiofrequency ablation.
Journal: Cancer cell international
Published: December 17, 2016
Oxidized low-density lipoprotein-induced microparticles promote endothelial monocyte adhesion via intercellular adhesion molecule 1.
Journal: American journal of physiology. Cell physiology
Published: June 02, 2016
A novel anti-inflammatory mechanism of high density lipoprotein through up-regulating annexin A1 in vascular endothelial cells.
Journal: Biochimica et biophysica acta
Published: October 19, 2015
Last Updated: 09/26/2026